Hala Koudsi, M.D.
NPI 1912097775 · Specialist · Torrance, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Hala Koudsi, M.D. is a Specialist provider in Torrance, CA (NPI 1912097775).
Provider details
- NPI number
- 1912097775
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- AO38441 (CA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
874 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 445 | $138 |
| Destruction of Skin Growth, 15 Or More Growths17111 | 101 | $150 |
| Destruction of Skin Growth, 1-14 Growths17110 | 70 | $120 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 63 | $179 |
| Punch Biopsy, First Skin Growth11104 | 46 | $139 |
| Removal of Noncancer Skin Growth of Body, Arms, Or Legs, 1.1-2.0 Cm |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 106 | 69 |
| Triamcinolone Acetonide | 94 | 74 |
| Hydrocortisone | 82 | 67 |
| Fluocinolone Acetonide | 62 | 46 |
| Minoxidil | 58 | 18 |
| Desonide | 51 | 39 |
| Fluocinonide | 28 | 21 |
| Doxycycline Hyclate | 28 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,563 across 66 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-10-13
- Last updated
- 2007-07-08
Frequently asked questions
- What is Hala Koudsi's NPI number?
- Hala Koudsi's National Provider Identifier (NPI) is 1912097775, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Hala Koudsi's specialty?
- Hala Koudsi is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Hala Koudsi located?
- Hala Koudsi's practice location on file with NPPES is 3655 Lomita Blvd Ste 215, Torrance, CA 90505-1916.
- What is Hala Koudsi's phone number?
- The practice phone number listed in the NPPES registry for Hala Koudsi is (310) 378-8885.
- Does Hala Koudsi accept Medicare?
- Hala Koudsi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Hala Koudsi's NPI active?
- Yes — Hala Koudsi's NPI (1912097775) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.